Contemporary Updates on Clinical Trials of Antiangiogenic Agents in the Treatment of Glioblastoma Multiforme

about

Contemporary Updates on Clinical Trials of Antiangiogenic Agents in the Treatment of Glioblastoma Multiforme

Item

http://www.wikidata.org/entity/Q57141680

description

wetenschappelijk artikel

@nl

name

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@en

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@nl

type

Item

label

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@en

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@nl

prefLabel

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@en

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@nl

P1476

Contemporary Updates on Clinic ...... ent of Glioblastoma Multiforme

@en

P2093

Aleka Scoco

http://www.w3.org/2001/XMLSchema#string

Arshneel Singh Kochar

http://www.w3.org/2001/XMLSchema#string

Maya Madhavan

http://www.w3.org/2001/XMLSchema#string

Robert T Geertman

http://www.w3.org/2001/XMLSchema#string

Sunil Manjila

http://www.w3.org/2001/XMLSchema#string

Vaijayantee K Belle

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Get a ligand, get a life: integrins, signaling and cell survival

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Requirement of vascular integrin alpha v beta 3 for angiogenesis

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma

Safety of anticoagulation use and bevacizumab in patients with glioma.

RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells.

Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

P304

546-554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/AJNS.AJNS_266_16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30283503

http://www.w3.org/2001/XMLSchema#string

P932

6159033

http://www.w3.org/2001/XMLSchema#string